Boost for Oxford Biomedica as Novartis files for further blood cancer indication 1 234 567

Boost for Oxford Biomedica as Novartis files for further blood cancer indication

livecharts.co.uk

Oxford Biomedica received a boost as Novartis announced that it has filed for approval of its Kymriah drug for a second blood cancer indication.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567